Literature DB >> 25096580

A residue-specific shift in stability and amyloidogenicity of antibody variable domains.

Cardine N Nokwe1, Martin Zacharias2, Hisashi Yagi3, Manuel Hora1, Bernd Reif1, Yuji Goto4, Johannes Buchner5.   

Abstract

Variable (V) domains of antibodies are essential for antigen recognition by our adaptive immune system. However, some variants of the light chain V domains (VL) form pathogenic amyloid fibrils in patients. It is so far unclear which residues play a key role in governing these processes. Here, we show that the conserved residue 2 of VL domains is crucial for controlling its thermodynamic stability and fibril formation. Hydrophobic side chains at position 2 stabilize the domain, whereas charged residues destabilize and lead to amyloid fibril formation. NMR experiments identified several segments within the core of the VL domain to be affected by changes in residue 2. Furthermore, molecular dynamic simulations showed that hydrophobic side chains at position 2 remain buried in a hydrophobic pocket, and charged side chains show a high flexibility. This results in a predicted difference in the dissociation free energy of ∼10 kJ mol(-1), which is in excellent agreement with our experimental values. Interestingly, this switch point is found only in VL domains of the κ family and not in VLλ or in VH domains, despite a highly similar domain architecture. Our results reveal novel insight into the architecture of variable domains and the prerequisites for formation of amyloid fibrils. This might also contribute to the rational design of stable variable antibody domains.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Amyloid; Antibody; Domain Architecture; Molecular Dynamics; Nuclear Magnetic Resonance (NMR); Protein Stability; Variable Domains

Mesh:

Substances:

Year:  2014        PMID: 25096580      PMCID: PMC4175325          DOI: 10.1074/jbc.M114.582247

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains.

Authors:  R Raffen; L J Dieckman; M Szpunar; C Wunschl; P R Pokkuluri; P Dave; P Wilkins Stevens; X Cai; M Schiffer; F J Stevens
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

2.  Influence of the internal disulfide bridge on the folding pathway of the CL antibody domain.

Authors:  Matthias J Feige; Franz Hagn; Julia Esser; Horst Kessler; Johannes Buchner
Journal:  J Mol Biol       Date:  2006-10-21       Impact factor: 5.469

3.  Ultrasonication-induced amyloid fibril formation of beta2-microglobulin.

Authors:  Yumiko Ohhashi; Miho Kihara; Hironobu Naiki; Yuji Goto
Journal:  J Biol Chem       Date:  2005-07-25       Impact factor: 5.157

4.  Amyloid fibrils formation and amorphous aggregation in concanavalin A.

Authors:  Valeria Vetri; Claudio Canale; Annalisa Relini; Fabio Librizzi; Valeria Militello; Alessandra Gliozzi; Maurizio Leone
Journal:  Biophys Chem       Date:  2006-08-02       Impact factor: 2.352

Review 5.  Prevention of amyloid-like aggregation as a driving force of protein evolution.

Authors:  Elodie Monsellier; Fabrizio Chiti
Journal:  EMBO Rep       Date:  2007-08       Impact factor: 8.807

6.  Mechanism of thioflavin T binding to amyloid fibrils.

Authors:  Ritu Khurana; Chris Coleman; Cristian Ionescu-Zanetti; Sue A Carter; Vinay Krishna; Rajesh K Grover; Raja Roy; Shashi Singh
Journal:  J Struct Biol       Date:  2005-09       Impact factor: 2.867

7.  The immunoglobulin superfamily: an insight on its tissular, species, and functional diversity.

Authors:  D M Halaby; J P Mornon
Journal:  J Mol Evol       Date:  1998-04       Impact factor: 3.973

8.  The CCPN data model for NMR spectroscopy: development of a software pipeline.

Authors:  Wim F Vranken; Wayne Boucher; Tim J Stevens; Rasmus H Fogh; Anne Pajon; Miguel Llinas; Eldon L Ulrich; John L Markley; John Ionides; Ernest D Laue
Journal:  Proteins       Date:  2005-06-01

Review 9.  Amyloidosis.

Authors:  Mark B Pepys
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

10.  Crosstalk between the protein surface and hydrophobic core in a core-swapped fibronectin type III domain.

Authors:  Kate S Billings; Robert B Best; Trevor J Rutherford; Jane Clarke
Journal:  J Mol Biol       Date:  2007-10-25       Impact factor: 5.469

View more
  6 in total

1.  Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.

Authors:  Pamina Kazman; Marie-Theres Vielberg; María Daniela Pulido Cendales; Lioba Hunziger; Benedikt Weber; Ute Hegenbart; Martin Zacharias; Rolf Köhler; Stefan Schönland; Michael Groll; Johannes Buchner
Journal:  Elife       Date:  2020-03-10       Impact factor: 8.140

2.  A single residue switch reveals principles of antibody domain integrity.

Authors:  Benedikt Weber; Matthias J Brandl; María Daniela Pulido Cendales; Carolin Berner; Tejaswini Pradhan; Gina Maria Feind; Martin Zacharias; Bernd Reif; Johannes Buchner
Journal:  J Biol Chem       Date:  2018-09-18       Impact factor: 5.157

3.  Effect of amino acid mutations on the conformational dynamics of amyloidogenic immunoglobulin light-chains: A combined NMR and in silico study.

Authors:  Sujoy Mukherjee; Simon P Pondaven; Kieran Hand; Jillian Madine; Christopher P Jaroniec
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

4.  MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.

Authors:  Manuel Hora; Riddhiman Sarkar; Vanessa Morris; Kai Xue; Elke Prade; Emma Harding; Johannes Buchner; Bernd Reif
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

5.  Epigallocatechin-3-gallate preferentially induces aggregation of amyloidogenic immunoglobulin light chains.

Authors:  Manuel Hora; Martin Carballo-Pacheco; Benedikt Weber; Vanessa K Morris; Antje Wittkopf; Johannes Buchner; Birgit Strodel; Bernd Reif
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

6.  Determinants of the assembly and function of antibody variable domains.

Authors:  Eva Maria Herold; Christine John; Benedikt Weber; Stephan Kremser; Jonathan Eras; Carolin Berner; Sabrina Deubler; Martin Zacharias; Johannes Buchner
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.